MTSR Stock Risk & Deep Value Analysis
MTSR
Healthcare • Biotechnology
DVR Score
out of 10
The Bottom Line on MTSR
We analyzed MTSR using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran MTSR through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.
📈MTSR Performance Overview3yr weekly
Unlock MTSR Performance Chart
See 3 years of price history, quarterly revenue trends, and DVR score changes
Weekly adjusted close · Quarterly revenue & EPS · DVR score history
MTSR Stock Risk Analysis
Overall Risk
Aggressive
Financial Risk
High
Market Risk
Medium
About MTSR (MTSR)
Sector
Healthcare
Industry
Biotechnology
Market Cap Category
small
Market Cap
$7.70B
MTSR Deep Value Analysis
MTSR Red Flags & Warning Signs
Premium- ⚠
Negative or inconclusive Phase 3 clinical trial results
- ⚠
Delays in clinical trial enrollment or regulatory processes
- ⚠
Failure to secure adequate funding for continued R&D and commercialization
- ⚠
Emergence of superior competing therapies from rivals
Unlock MTSR Red Flags & Risk Warnings
Premium members see every risk event we found.
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
Unlock everything for $47/yr
$79/yrSave 41%
- ✓ Catalysts, bull case, moat & red flags
- ✓ Unlimited stock analyses + alerts
- ✓ Full database, search & portfolio (50 stocks)
7-day money back · Cancel anytime
MTSR Financial Health Metrics
Market Cap
$7.70B
MTSR Competitive Moat Analysis
PremiumMoat Rating
Narrow
Moat Trend
Expanding
Moat Sources
2 Identified
The moat's durability is highly contingent on successful late-stage clinical trials, robust and expanding patent protection for its mRNA platform and specific drug candidates, and the ability to scale manufacturing. If successful, MTSR could establish a strong first-mover advantage and create significant switching costs for patients and healthcare providers due to superior efficacy/safety profiles.
MTSR Competitive Moat Analysis
Premium unlocks moat rating, sources & durability.
MTSR Catalysts & Growth Drivers
Near-Term (0-6 months)
- •Phase 3 clinical trial initiation and patient enrollment updates (Q2-Q3 2026)
- •Presentation of detailed Phase 1/2 data at major medical conferences (H1 2026)
- •Potential expansion of strategic partnership scope or new collaboration announcements (H1 2026)
Medium-Term (6-18 months)
- •Interim data readout or key milestone achievement in Phase 3 trials (H2 2026 - H1 2027)
- •Regulatory interactions for Breakthrough Therapy or Fast Track designations
- •Pipeline expansion into additional indications using mRNA platform (2027)
Long-Term (18+ months)
- •Successful Phase 3 trial completion and positive top-line results (2028-2029)
- •Regulatory approval and market launch of MTSR-001 (2029-2030)
- •Establishment as a market leader in mRNA-based autoimmune/oncology therapies
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
MTSR Bull Case: What Could Go Right
- ✓
Positive updates on Phase 3 trial enrollment and progress
- ✓
Extension or expansion of existing strategic partnerships
- ✓
Cash runway updates and successful financing rounds
- ✓
Any signs of competitive setbacks or regulatory hurdles
Bull Case Analysis
See what could go right with Premium
Never miss a move on MTSR
Create a free account to set price alerts and get notified on Telegram when MTSR hits your targets.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.
FAQ
What is the DVR Score for MTSR (MTSR)?
As of February 10, 2026, MTSR has a DVR Score of 7.8 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of MTSR?
MTSR's market capitalization is approximately $7.7B. The company operates in the Healthcare sector within the Biotechnology industry.
What ticker symbol does MTSR use?
MTSR is the ticker symbol for MTSR. The company trades on the NMS.
What is the risk level for MTSR stock?
Our analysis rates MTSR's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
How often is the MTSR DVR analysis updated?
Our AI-powered analysis of MTSR is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on February 10, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.